Search Within

Geoffrey Yuyat Ku

  1. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (73)
  2. Journal Article (3)
Groups
  1. Department of Medicine (76)
  2. Gastrointestinal Oncology Service (76)
  3. Hematologic Malignancies, Division of (76)
  4. Solid Tumor Oncology Division (76)
  5. Center for Pancreatic Cancer Research (43)
  6. Epidemiology and Biostatistics (38)

More Groups

People
  1. David Ilson (50)
  2. Yelena Janjigian (49)
  3. David Kelsen (27)
  4. Marinela Capanu (26)
  5. Steven Maron (20)
  6. Joanne Chou (19)

More People

Years
  1. 2025 (6)
  2. 2024 (6)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (7)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (76)
Publishers
  1. American Society of Clinical Oncology (76)

Results (76)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2(+)advanced solid tumors
    Meeting Abstract

    Sohal, D.; Iqbal, S.; Turcotte, S.; Botta, G. P.; Schlechter, B. L.; Ku, G. Y.; Hosein, P. J.; Saibil, S.; Gavriliuc, M.; Apostolopoulou, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab and chemotherapy versus chemotherapy in advanced metastatic gastroesophageal adenocarcinoma: The phase III, randomized LEAP-015 study
    Journal Article

    Shitara, K.; Lorenzen, S.; Li, J.; Bai, Y. X.; Fernández, M. G.; Aguilar, M.; Shoji, H.; Reyes-Cosmelli, F.; Peña, Y. R.; Corrales, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase I trial of intraperitoneal (IP) mesothelin (MSLN)-targeted CAR T-cell therapy in patients with MSLN-positive esophagogastric cancer (EGC) with peritoneal carcinomatosis
    Meeting Abstract

    Choo, J.; Saini, J.; Gonzalez-Aguirre, A.; Dahi, P.; Hieronymi, S.; Fernstedt, S.; Tan, K. S.; Adusumilli, P. S.; Ku, G. Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2+ advanced solid tumors
    Meeting Abstract

    Dumbrava, E. E.; Iqbal, S.; Turcotte, S.; Botta, G. P.; Schlechter, B. L.; Ku, G. Y.; Hosein, P. J.; Saibil, S.; Gavriliuc, M.; Apostolopoulou, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between adjuvant component of perioperative chemotherapy and survival outcomes in resected gastric cancer (GC)
    Meeting Abstract

    Sreeram, A.; Yeh, C.; Toumbacaris, N.; Capanu, M.; Shimada, S.; Gu, P.; Janjigian, Y. Y.; Ilson, D. H.; Strong, V. E.; Ku, G. Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • NRG-GI007: Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer
    Meeting Abstract

    Ku, G. Y.; Moughan, J.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Mehta, R.; Frakes, J. M.; Wu, A. J. C.; Miller, E. D.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial
    Meeting Abstract

    Botta, G. P.; Kelly, R. J.; Jin, Z.; Ma, H.; Ku, G. Y.; Zhao, D.; Mehta, R.; Carnevale, J. C.; Sierra, G.; Jia, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007
    Meeting Abstract

    Ku, G. Y.; Moughan, J.; Williams, T. M.; Adusumilli, P. S.; Nishimura, M.; Yock, A.; Mehta, R.; Klempner, S. J.; Miller, E. D.; Hong, T. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Trivedi, N.; Maron, S. B.; Joshi, S. S.; Ilson, D. H.; Janjigian, Y. Y.; Shcherba, M.; Li, J.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save